World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
59110
World Ranking
17779
National Ranking
746

Morris Sherman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Morris Sherman sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 258 publications — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Morris Sherman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Morris Sherman sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Morris Sherman is affiliated with the University Health Network in Canada and specializes in the field of medicine with a strong focus on epidemiology and hepatology. Their research is particularly centered on liver disease diagnosis and treatment, hepatitis B and C virus studies, and hepatocellular carcinoma treatment and prognosis. Their work also touches on liver disease and transplantation as well as cancer genomics and diagnostics.

The scientist has contributed to a range of publications in various medical journals. Frequent publication venues include:

  • JHEP Reports
  • Gastroenterology
  • Hepatology Communications
  • Hepatology
  • Liver International

Morris Sherman's recent papers highlight significant topics in liver disease and cancer research. Among these are:

  • International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma, 2021, Gastroenterology
  • A multi-analyte cell-free DNA-based blood test for early detection of hepatocellular carcinoma, 2022, Hepatology Communications
  • What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association, 2022, JHEP Reports
  • The viral hepatitis B care cascade: A population-based comparison of immigrant groups, 2021, Hepatology
  • Viral hepatitis C cascade of care: A population-level comparison of immigrant and long-term residents, 2021, Liver International

The scientist frequently collaborates with other researchers in related fields. Their notable coauthors include:

  • Jordan J. Feld
  • Yujin Hoshida
  • Abdool S. Yasseen
  • Jeffrey C. Kwong
  • Rafal Kustra

Morris Sherman's subfields of study are distributed across epidemiology, hepatology, cancer research, pharmacology, and surgery, illustrating a multidisciplinary approach within medical sciences. Their focus on epidemiology includes 15 publications, while hepatology accounts for 9, complemented by work in cancer research.

The main topics of Morris Sherman's scientific work include:

  • Liver Disease Diagnosis and Treatment
  • Hepatitis B Virus Studies
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatitis C virus research
  • Liver Disease and Transplantation
  • Cancer, Lipids, and Metabolism
  • Cancer Genomics and Diagnostics

Best Publications

  • Management of hepatocellular carcinoma: An update

    Jordi Bruix;Morris Sherman

  • Management of hepatocellular carcinoma.

    Jordi Bruix;Morris Sherman

  • Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference

    Jordi Bruix;Morris Sherman;Josep M Llovet;Michel Beaugrand

  • Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

    Josep M. Llovet;Adrian M. Di Bisceglie;Jordi Bruix;Barnett S. Kramer

  • Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma.

    Jordi Bruix;Maria Reig;Morris Sherman

  • Global patterns of hepatocellular carcinoma management from diagnosis to death: The BRIDGE Study

    Joong Won Park;Minshan Chen;Massimo Colombo;Lewis Rowland Roberts

  • Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial.

    Jordi Bruix;Jean Luc Raoul;Morris Sherman;Vincenzo Mazzaferro

  • Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis

    L Bolondi;S Sofia;S Siringo;S Gaiani

  • Sequential Phase I and II Trials of Stereotactic Body Radiotherapy for Locally Advanced Hepatocellular Carcinoma

    Alexis Bujold;Christine A. Massey;John J. Kim;James Brierley

  • Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study

    Josep M. Llovet;Thomas Decaens;Jean-Luc Raoul;Eveline Boucher

  • Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

    Regina V. Tse;Maria Hawkins;Gina Lockwood;John J. Kim

  • Tivantinib for second-line treatment of advanced hepatocellular carcinoma: A randomised, placebo-controlled phase 2 study

    Armando Santoro;Lorenza Rimassa;Ivan Borbath;Bruno Daniele

  • Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B.

    Morris Sherman;Cihan Yurdaydin;Jose Sollano;Marcelo Silva

  • LI‐RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI‐RADS Management Working Group and future directions

    Donald G. Mitchell;Jordi Bruix;Morris Sherman;Claude B. Sirlin

  • Biology and significance of alpha-fetoprotein in hepatocellular carcinoma.

    Peter R Galle;Friedrich Foerster;Masatoshi Kudo;Stephen L Chan

  • Historical epidemiology of hepatitis C virus (HCV) in selected countries

    P. Bruggmann;T. Berg;A. L. H. Øvrehus;C. Moreno

  • The role of hepatic resection in the treatment of hepatocellular cancer

    Sasan Roayaie;Ghalib Jibara;Parissa Tabrizian;Joong Won Park

  • Once-Daily Simeprevir (TMC435) With Pegylated Interferon and Ribavirin in Treatment-Naïve Genotype 1 Hepatitis C: The Randomized PILLAR Study

    Michael W. Fried;Maria Buti;Gregory J. Dore;Robert Flisiak

  • Hepatocellular Carcinoma (HCC): A Global Perspective

    Peter Ferenci;Michael Fried;Douglas Labrecque;Jordi Bruix

  • Strategies to manage hepatitis C virus (HCV) disease burden

    H Wedemeyer;A S Duberg;M Buti;W M Rosenberg

Frequent Co-Authors

Harry L.A. Janssen
Harry L.A. Janssen Erasmus University Rotterdam
Mel Krajden
Mel Krajden University of British Columbia
Paul D. Greig
Paul D. Greig Toronto General Hospital
Masao Omata
Masao Omata University of Tokyo
Richard S. Finn
Richard S. Finn University of California, Los Angeles
Mark W. Tyndall
Mark W. Tyndall University of British Columbia
Gideon M. Hirschfield
Gideon M. Hirschfield University Health Network
Soo Young Park
Soo Young Park Seoul National University
Zahid A Butt
Zahid A Butt University of Waterloo
Ronnie T.P. Poon
Ronnie T.P. Poon University of Hong Kong

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are interested in healthcare but are exploring alternatives to studying Medicine in the USA, online degrees offer flexible and accessible paths. For those wanting to enter the workforce quickly, fast track lpn programs are ideal for starting a practical nursing career in less time.

For nurses seeking to specialize further, the fastest psychiatric nurse practitioner program options allow RNs to advance rapidly into mental health and psychiatric care roles.

Not all healthcare careers require direct patient care. A management track can begin with the cheapest online healthcare administration degree, which equips students with business and leadership skills necessary for running clinics or hospitals.

For even greater advancement, consider the cheapest mha online programs. A master’s in healthcare administration opens opportunities for executive and policy-making positions as you help shape the future of healthcare delivery in the US.

Best Scientists Citing Morris Sherman

Trending Scientists

Recently Published Articles